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We observed that L-fucose could suppress the skin 
reaction of allergic contact dermatitis induced by dini-
trochlorobenzene. This observation was ascertained by 
histological examination as well as by visual inspection. 
The degrees of the acanthosis and the spongiosis were 
significantly slighter in the skin lesions of guinea pigs 
that received L-fucose injection, than in those of control 
animals. The number of infiltrated mononuclear cells in 
epidermis and dermis in the skin lesions was much less 
in the animals received L-fucose injection than that in 
the skin lesions of control animals. 
On the other hand, L-fucose had no suppressive effect 
on irritant contact dermatitis induced by high concen-
tration (4 %) of dinitrochlorobenzene. 
Allergic contact dermatitis is generally accepted as manifes-
tation of cell-mediated immunity. Its histologica l findings con-
sist of epidermal cell damage and mononuclear cell infiltration 
in epidermis a nd dermis. Infiltration of mononuclear cells begins 
first in the dermis at 3 hr after the induction as shown by light 
microscopy (1]. On electron microscopic examination, apposi-
tion of mononuclear cells, resembling lymphocytes, to the epi-
dermal Langerhans cells is exhibited also at 3 h1· (2] and early 
changes of epidermal cells are revealed at 6 hr (3]. The epider-
mal c.:ell damage as well as infiltration of mononuclear cells in 
the epidermis and the dermis become evident at 12 to 24 ill· ( 4) 
However, the inflammatory m ediators leading to these mor-
phological changes still remains unclarified . 
L-fucose has been shown capable of inhibiting lymphokine 
activities in vitro system (5-7]. In a previous study (8], we 
demonstrated that L-fucose can inhibit lymphokine activities 
in vivo; L-fucose inhibited the ability of lymphokine-containing 
supernatants of lymphocytes culture to induce skin reactions 
or cause r eduction in the macrophage content of peritoneal 
exudates. L-fucose could inhibit the cutaneous delayed type 
hypersensitivity reactions of the guinea pigs. 
Modification of allergic contact dermatitis by L-fucose, if 
possible, seems to provide a good clue for clarification of the 
mediators in the inflammatory processes of allergic contact 
dermatitis . Then, in the present study the effect of L-fucose on 
allergic contact dermatitis was stud ied. 
MATERIALS AND METHODS 
In du ction. of Contact Sensitivity 
·Hartley albino female guinea 'pigs weighing 350 to 400 gm were used. 
Contact sensitivi ty to dinitrochlorobenzene (DNCB) was induced by 
11 da~y paintings on the clipped nape with 0.5 ml of 2.5% DNCB 
acetone solution. 
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Abbreviations: 
DNCB: dinitrochlorobenzene 
MIF: migration inhibitory factor 
PBS: phosphate buffered saline 
Challenge Testing of S ensitized Anim.als 
Fifteen days later the last painting with DNCB, the guinea pigs were 
challenged by applying 50 J.LI of 0.08% DNCB acetone solution on the 
clipp~d back. Twenty-four hours after challenging, the degree of skin 
reactiOn w~s described according to scoring s~stem established b y 
Chase (9]. 1 he gradmg of the mflammatory reactiOns were: 0, negative· 
±, many faint pink small spots or few fain t pink spots; 1 +, faint pink: 
2+, pale pink; 3+, pink but either somewhat pale or macular; 4+, pink 
usually very slightly elevated. 
Monosaccharides 
a-L-fucose and L-arabinose were purchased from Sigma Chemicals 
California, USA. These sugars were dissolved in phosphate buffered 
saline (PBS) at a concentration of 0.5 M. 
RESULTS 
Effect of L-Fucose on the Shin Reactions of Allergic Contact 
Dermatitis 
A total of 24 guinea pigs sensitized previously with DNCB 
were divided into 3 groups of 8 guinea pigs each. In our previous 
study of suppression of lymphokine activities by L-fucose, in-
travenous (i.v.) injection of 0.5 M L-fucose simultaneously at 
the t ime of injection of lymphokines or challenging antigens 
into the animals provided us successful results (8]. Then, in the 
present study, effect of L-fucose on allergic contact dermatitis 
was studi ed in an identical manner . L-arabinose showed no 
suppressive effect on lymphokine activities in the previous 
study and was used as a control sugar in the present study. All 
of the 3 groups were challenged with 0.08% DNCB acetone 
solution. The first group was injected intravenously with 0.5 M 
L-fucose in 1 ml of PBS. The second group was injected 
intravenously with 0.5 M L-arabinose in 1 ml of PBS simulta-
neously. No toxicity was noted with L-fucose or L-arabinose 
preparation used as described previously (8]. The last group 
received no intravenous injection. The latter two groups served 
as the controls. The results are shown in Table I. Animals 
receiving L-fucose injection showed s ignificant reduction of skin 
reactions with respect to elevation and intensity of erythema. 
In contrast, the skin reactions of animals that received L-
arabinose were not significantly different in intensity fi-om those 
of noninjected animals as indicated by the scoring system. 
Considering the possibility that the degree of sensitization or 
the intensity of reaction might be uneq ual among individuals 
we explored the ability of L-fucose to suppress allergic contact 
der~atitis in t~e- same . sensitized guinea pigs. Six guinea pigs 
prevwusly sensitized w1th DNCB were prepared. First, all the 
guinea pigs were challenged with DNCB. Forty-eight hours 
later, they were divided into 2 groups of 3 guinea pigs each. 
One group of the animals was rechall enged on a different skin 
site and simultaneously given an injection of L-fucose. As a 
contro l, the other group was rechallenged without injection of 
L-fucose. Suppressive effect of L-fucose on lymphokine acti-vi-
ties did not remain in the animals at 48 hr after L-fucose 
injection (Baba T., Yoshida T ., a nd Cohen S., unpublished 
data) . Then further, 48 hr later, all the 6 animals were chal-
lenged on the other different skin site. We were able to achieve 
a significant reduction in the intensi ty of skin reaction with 
intravenous injection, as compared to the first and third chal-
lenge. The skin reactions of the second challenge on the control 
animals showed no significant diffe rence in the intensity as 
compared to the first and thiJ·d chall enge (Fig 1). 
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TA B I~E I. E((ec/ of L -(u cose on the shin reactions in a llergic conla.c/ 
derma. / it is" 
Chm;c's scores·· 
Guin ea pig 
No." Sugars injel:t.ed i.v." 
L-fucose L-arabinose Non treated 
1 ±f' 3+ 3+ 
2 ]+ 3+ 4+ 
3 ]+ 4; 4+ 
4 I • 2+ 3+ 
5 l + 3+ 2+ 
6 2+ 4+ 4+ 
7 ± 2; 2+ 
8 2+ 3+ 3+ 
"Contact sensitivity to DNCB was induced by U daily paintings on 
t he clipped nape wi th 0.5 ml of 2.5% DNCB acetone solution. Fifteen 
days later the last pain ling wi th DNCB, the guinea pigs were challenged 
by applying 50 I' I of 0.08% DNCB acetone solu tion on the clipped back. 
" A tota l of 24 guinea pigs sensitized previously wi th DNCB were 
divided in to 3 groups of 8 guinea pigs each. 
,. T wenty-four hours afte r challenging, the degree of skin reaction 
was described according to scoring system esta blished by Chase. 
" Monosaccharide solu tions (0.5 M) were inj ected in travenously at. 
t he t ime of challenge tests. 
Challenge Challenge Challenge 
I I I 
G.P. 1 3+ 1+ 3+ (") :::::; 
[__ _l _J Q.l (/l 
4+ 2+ 3+ CD G.P. 2 (/l' 
[___ (/) (') 
3+ 1+ 4+ 0 G.P. 3 ...., CD (/l 
... 
FUCOSE 
G.P. 4 4+ 4+ 4+ (") :::::; 
I~ Q.l (/l 
3+ 4+ 4+ CD G.P. 5 (/l' 
(/) 
(') 
3+ 4+ 4+ 0 G.P. 6 ...., CD 
t..-----1 (/l 
0 24 48 72 96 120 
hrs after induction 
F IG 1. The abili ty of L-fu cose to sup pre ·s allergic contact dermatitis 
in the same sensitized guinea pigs. First, the guinea pigs were challenged 
by DNCB. Forty-e ight hours later they were recna llenged on a different 
s kin site and simul taneously injected in traveJ1ously wi th L-fu cose. 
F urther, 2 days late r, they were cha llenged on th e other different skin 
s ite without in travenous injection. A s ignifican ~ reduction was shown 
in the in tensity of skin reaction with in travenous injection, as compared 
to the first challenge and the third one (G.P. 1-3). G.P. 4-6 are 
noninjected control animals. 
Histological Examination of Shin R eaction s 
R eaction s ite from individual a nima ls were biopsied a nd 
histological exa mination utilizing sectionB rou t inely stained 
with he matoxylin a nd eosin was performed. The skin lesions 
from nont reated guinea pigs sh owed acan th osis, spongiosis a nd . 
infil t ration of m ononuclear cells to epidermis a nd in dermis. 
T h e s kin lesions from L-ara binose injected ~nimals were almost 
t h e sam e as those of non trea ted a nimals orl histological study. 
Howeve r, compa red with these control a flima ls, in t he skin 
lesions of guinea pigs that received L- fuco~e injection the de-
grees of the acan thosis a nd the spongiosiG were s ignifica ntly 
s lighter . Moreover , the number of infil t ra tecl m ononuclear cells 
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in epidermis a nd dermis in t he skin lesions was m uch less in 
t he a nima ls received L-fucose injection t ha n t hat in the skin 
lesions of t he con trol a nimals (Fig 2). 
E ffec t of L-Fucose on. Previously Induced A llergic Contact 
Dermatitis 
T o study whether s imul taneous injection of L-fucose at t he 
time of challenging is necessary fo r sup pression of allergic 
contact dermatit is, the effect of L-fucose on 6-hr-old all e rgic 
con tact dermatit is was studied. The ea rly cha nges of epiderma l 
cells in t he alle rgic con tact dermatit is a re vis ible on th e electron 
microscopic study at 6 hr a fter t he induction [3]. Nine guinea 
pigs previously sensitized with D N CB were prepared a nd d i-
vided in to 3 groups. All of t he 3 groups were chall enged with 
0.08% DNCB acetone solu t ion . F i1·st group was received s im ul-
FIG 2. Histological examination of skin reactions (X 100). T he de-
grees of the acanthosis and the spongiosis were signi fica ntly slighter in 
the skin le ions of guinea pigs that received L-fucose injection (A), than 
in those of' nontreated animals (B). T he number of infiltrated mono-
nuclear cells in epidermis and dermis in the skin lesions was much less 
in the animals received L-fu cose injection (A) than that in the skin 
lesions of nontreated animals (B). 
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TABLE II. Effect of L-fucose on. previously induced alle1gic contact 
dermatitis" 
Chase's sco res'· 
Guinea pig 
No -" 













"ConiacL sensitiv ity to DNCB was induced by 11 da ily pa in t ings on 
the cl ipped nape with 0.5 ml of 2.5% DNCB acetone solu tion. Fifteen 
days later the last painting with DNCB, the guinea pigs were challenged 
by applying 50 J.d of 0.08% DNCB acetone solution on the clipped back. 
" A total of 9 guinea pigs sensiti:ted previously with DNCB were 
divided in to 3 groups of 3 guinea pigs each. 
,. Twenty-four how-s after challenging, the degree of skin reaction 
was described according to scoring system established by Chase. 
" F irsi group was received i.v. inj ection of L-fucose at the t ime of 
challenge tesis. 
' T he second group was received i.v. injection of same dose of L-
fucose at 6 hr after cha llenging. 
' T he third group received no i.v. injection. 
taneous i.v. injection of 1 m1 of 0.5 M L-fucose. The second 
group was received i.v. injection of same dose of L-fucose at 6 
hr after challenging. The third group received no i.v. injection. 
As shown in Table II, animals receiving L-fucose injection at 6 
hr after the challenging showed significant reduction of skin 
reactions. No significant difference was observed between the 
skin reactions of the fu·st group which received simultaneous L-
fucose injection and those of the second group which received 
L-fucose injection at 6 hr after the cha llenging. 
Effect of L-Fucose on Irritant Contact Dermatitis Induced by 
DNCB 
In our previous study of irritant contact dermatitis induced 
by 4% DNCB acet9ne solution [10] , it was demonstrated that 
irritant contact dermatitis generated C3-dependent neutrophil 
chemotactic activity in its inflammatory processes at 6 hr after 
the induction. T he number of neutrophils infiltrated in the 
lesion seemed to be parallel with the degree of the neutrophil 
chemotactic activity in the lesion; the degree of neutrophil 
chemotactic activity reached a peak at 12 to 24 hr after the 
induction, when the lesion was found to be infiltrated predom-
inantly with neutrophils. 
Effect of L-fucose on irritant contact dermatitis was studied. 
E ight gu inea pigs were prepared and divided into 2 groups. One 
group of the animals was received 1 ml of 0.5 M L-fucose i.v. 
injection simultaneously at the time of induction of irritant 
contact dermatitis by 4% DNCB acetone solution. Ano ther 
group received no i.v. injection as a control. The skin reactions 
showed no significant difference between 2 groups in their 
intensity of erythema and In their histological finclings; t he 
degree of epidermal damage and the number of infiltrated cells 
in dermis. 
.Although the attempts were made to suppress the 4% DNCB-
induced ir~·itant contact dermatitis by L-fucose with higher 
conceptratwns (1 rnl of 1 M and 1 rnl of 2 M L-fucose respec-
tively), no suppressive effects were obtained. No toxic effect of 
L-fucose on the an imals was noted even with high concentration 
of L-fucose, such as 1 M or 2 M. 
Croton oil, instead of DNCB, wa · used to induce irrita nt 
contact dermatitis. L-fucose did not suppress these irritant 
contact dermatitis when 1 ml of 0.5 M, 1 M and 2 M respectively 
was injected. 
DISCUSSION 
L-fucose, which is monosaccha1·ide, has been shown to be an 
inhibitor of lymp hokine activi ties from the foll owing observa-
tions. Remold has reported that L-fucose blocks the action of 
Vol. 75, No. 3 
macrophage migration inhibitory factor (MIF) [5], and Rocklin 
has also demonstrated that huma n lymphocyte MIF activity on 
human blood monocytes is reduced by L-fucose [6]. Amsd~n et 
a l have found that L-fu cose is able to inhibi t t he lymphokine 
activities . of macrophage. migration inhibition, macrophage 
c~emotax1s and_ neutrophil chemotaxis, whereas nonlympho-
kme chemotactic factors such as those derived from comple-
me_nt components or bac_teria1 products are not influenced by 
L-fucose [7]. In our prevwus study [8], L-fucose could inhibit 
in an in vivo assay system, the ability of l~mphokine-containin~ 
supernatants of lymphocyte culture to mduce skin reactions 
that mimicked a delayed type hypersensitivity reaction o r to 
cause reduction in the macrophage content of peritoneal exu-
dates. Although the lymphokine-free control superna tants in -
duced nonspecific inflammatory reactions, t hese were not ca-
pable of L-fucose inhibition. The Arthus reaction, which has 
been accepted by Ward and Hill as a manifestation of C5-
mediated reaction [ll] , could not be suppressed by L-fucose. L-
fucose had no suppressive effect on histamine-induced vascular 
permeability. (Baba T ., Yoshida T . and Cohen S., unpublished 
data). 
In the present study, it was demonstrated that allergic contact 
dermatitis was suppressed by L-fucose, when previously sensi-
ti_zed anin:a!s w_ere challenged with DNCB and simultaneously 
giVen an mJectwn of L-fucose. Based on the observations de-
scribed above, the suppression mechanism of L-fucose on al-
lergic contact dermatitis may be due to inhibitory action of L-
fucose on the activity of 1ymphokines generated in the lesion. 
Then, we presumed that production of lymphokines occur in 
allergic contact dermatitis and the 1ymphokines play a predom-
inant role in the inflammatory processes. 
Epidermal Langerhans cells have been demonstrated to have 
antigen-presenting ability to T -lymp hocytes [12] and their mac-
rophage like properties have been also exhibited; Langerhans 
cells bear Fe and C3 receptors [13] as well as Ia antigen at the 
smface [14]. In addition, it has been demonstrated that Lan-
gerhans cells can induce an antigen-specific T -cell proliferation 
response comparable in magnitude to that induced by macro-
phages [12]. On the other hand, Silberberg, Baer, and Rosenthal 
h~ve exibited on the electron microscopic study the apposition 
of m~nonucleaT cells, resembling lymphocytes, to Langerhans 
cells 111 the e~idermis of allergic contact dermatitis as early as 
3 hr after the mduction ~2]. Then, al_though it has been generally 
a~cepted that lymphokme-productwn ofT-lymphocytes is me-
diated. by macr~~hag~s, the lymphokines generated in allergic 
contact dermatitis might be mediated by the epidermal Lan-
gerhans cells. 
. I_n a llergic contact dermatitis, epidermal cell damages are 
VISible at 6 hr on the electron microscopic examination when 
the apposi t~on of mononuclear cells to Langerhans cells' is also 
observed [3]. In the present study, L-fucose showed remarkable 
suppressive effect on the allergic contact dermatitis of animals 
when i~j ecte~ at 6 ru·. Thus, it seems to be likely that th~ 
predo_mmant mflammatory mediators in all ergic contact der-
mati~I s afte1· starting the epidermal cell damages are still lym-
phokn~es and that modification of inflammatory processes by 
the epidermal cell damages is few, if any, in this case. In the 
irri tant contact dermatitis induced by 5% DNCB, S ilberberg, 
Baer, ~nd Rosenthal have reported by electron microscopy tha t 
the epidermal ~ell d;;tmages are observed also at 6 ru· [2], though 
not accompamed with apposition of mononuclear cells to Lan-
gerhans cells. In our previous study of the irri tant contact 
dermatitis induced by 4% DNCB [10] , we demonstrated the 
appearance of C3-dependent neutrophil chemotactic factors in 
the l_esi_on after 6 hr. L-fucose exibited no suppressive effect on 
the rrntant contact dermatitis induced by 4% DNCB in the 
present study. Then, the inflammatory processes of allergic 
contact dermatitis seem to be independent from those of irri tant 
contact dermatitis. 
The present experiments demonstrated that L-fucose which 
is a monosaccharide, could inhibit alJ ergic contact den;1atitis. 
S ep t. 1980 
L-fucose did not show significant toxicity to animals so far we 
exam ined. In addition, it has been repor ted that normal human 
serum contains L-fucose in a small a mount [15]. T hus, L-fucose 
migh t be able to use for the regula tion of human allergic contact 
derm atitis. Moreover , L-fucose showed no suppressive effect on 
irritan t contact dermatitis and one might be able to differentiate 
allergic contact dermatitis from irritant contact dermati tis from 
t he effectiveness of L-fucose on the lesion. 
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